- Home
- Primary Care
- Long‑Term Protection Against Oncogenic HPV Types: Evidence from a Phase III Study
9mo3 min read
Medical Article
Introduction: Human papillomavirus (HPV) is the most common sexually transmitted infection globally, with persistent infection by certain oncogenic HPV types linked to cervical, vulvar, vaginal, and other anogenital cancers (1). While the initial quadrivalent HPV vaccine covered four key genotypes, Gardasil 9, a nine-valent vaccine, was developed t

Long‑Term Protection Against Oncogenic HPV Types: Evidence from a Phase III Study
432 Reached1 Comments
Similar Content

Acute Renal Failure in Child Due to High Dose of Indomethacin
685 Reached6 Comments

Woman presented with Fever of Unknown Origin
7744 Reached93 Comments19 Likes

How Physicians Should Manage Stress?
35340 Reached151 Comments202 Likes

Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes

Rubella Syndrome in Neonate
1403 Reached12 Comments9 Likes
